AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Founded Date:
N/A
Headquarters:
Denmark
Technology:
COVID
Employee Number:
N/A
Industry:
Vaccine/Drug
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A